Latest news with #financialPerformance
Associated Press
09-07-2025
- Business
- Associated Press
PB Financial Corporation Declares Third-Quarter, 2025 Dividend
ROCKY MOUNT, NC / ACCESS Newswire / July 9, 2025 / Ted E. Whitehurst, President and CEO of PB Financial Corporation (OTCQX:PBNC), the holding company for Providence Bank, announced today that the Board of Directors approved a quarterly cash dividend of $0.59 per share on common stock outstanding to shareholders of record at the close of business on August 1, 2025. The dividend is payable August 22, 2025. This is an increase of approximately 9.26% from the dividend paid during the 3rd quarter of 2024. This represents a $2.36 per share dividend on an annualized basis and a dividend yield of approximately 4.72% (based on closing price of July 8, 2025 of $50.00 per share). Whitehurst commented, 'This represents our 55th consecutive quarterly cash dividend. Our consistent financial performance has allowed us to increase our cash dividend each quarter since we began paying dividends in the 1st quarter of 2012. This increase in our quarterly cash dividend is part of our continued strategy to enhance shareholder value which we believe sets us apart from other community banks.' PB Financial Corporation is headquartered at 450 N. Winstead Avenue in Rocky Mount, North Carolina. As of June 30, 2025, PB Financial Corporation had total assets of $1.402 billion, loans of $1.176 billion and total deposits of $1.186 billion. This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding PB Financial Corporation. Those statements may include but are not limited to statements regarding the Company's plans, objectives, expectations and intentions and other statements identified by words such as 'believes,' 'considers,' 'expects,' 'anticipates,' 'estimates,' 'intends,' 'plans,' 'targets,' 'projects,' 'would be,' and similar expressions. These statements are based upon current beliefs and expectations of management of PB Financial Corporation and are subject to significant risks and uncertainties. Actual or future results or events may differ from those set forth in the forward-looking statements. PB Financial Corporation does not undertake to update any forward-looking statements in this press release. The information as of and for the quarter ended June 30, 2025 as presented is unaudited. For more information, contact: July 9, 2025 Ted E. Whitehurst, President and CEO 252-467-2990; [email protected] SOURCE: PB Financial Corp press release
Yahoo
24-06-2025
- Business
- Yahoo
Cyanotech Corp (CYAN) Q4 2025 Earnings Call Highlights: Strong Sales Growth Amidst Financial ...
Release Date: June 24, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Cyanotech Corp (CYAN) reported a 5% growth in net sales for the fiscal year 2025. The company achieved an 11% improvement in expenses due to efficiencies in production and tight inventory management. Bulk spirulina and Bulkasa Xanthin sales grew significantly by 53% and 74% respectively. Gross profit margin improved to 28.4% for the fiscal year, up from 25.8% the previous year. Operating loss for the fiscal year decreased to $2.5 million from $4.6 million in the prior year. Net loss for the fiscal year was $3.2 million, although reduced from the previous year's $5.3 million. Cash reserves decreased to $257,000 at the end of the fiscal year, down from $707,000 the previous year. Working capital also declined to $302,000 from $2 million at the end of fiscal year 2024. Package sales declined by about 5%, offsetting some of the gains in bulk product sales. Despite improvements, the company still reported a net loss per diluted share of $0.45 for the fiscal year. Warning! GuruFocus has detected 6 Warning Signs with CYAN. Q: Can you provide an overview of Cyanotech Corp's financial performance for the fourth quarter and fiscal year 2025? A: Jennifer Rogerson, CFO, reported that net sales for the fourth quarter were $6.3 million, up from $6 million the previous year, marking a 5.5% increase. For the fiscal year, total sales reached $24.2 million, a 5% increase from $23.1 million last year. The gross profit for the fourth quarter was $1.7 million with a margin of 27.7%, compared to $675,000 and 11.3% in the previous year. The fiscal year gross profit was $6.9 million with a margin of 28.4%, up from $5.9 million and 25.8% last year. The operating loss for the fourth quarter was $442,000, significantly reduced from $1.9 million the previous year. The fiscal year operating loss was $2.5 million, down from $4.6 million in 2024. The net loss for the quarter was $627,000 or $0.09 per diluted share, compared to $2.1 million or $0.30 per share last year. The full-year net loss was $3.2 million or $0.45 per share, compared to $5.3 million or $0.81 per share last year. The company ended the fiscal year with $257,000 in cash and $302,000 in working capital, down from $707,000 and $2 million, respectively, at the end of 2024. Q: What were the key factors contributing to the financial results? A: Matt Custer, CEO, highlighted that the 5% growth in net sales was driven by efficiencies in production and tight inventory management, which also contributed to an 11% improvement in expenses. The product mix shifted, with bulk spirulina and Bulkasa Xanthin sales growing by 53% and 74%, respectively, although there was a 5% decline in package sales. Strategic initiatives, including hiring a head of sales to expand retail channels, were also significant contributors. Q: How did Cyanotech Corp manage its inventory and cash flow? A: Matt Custer, CEO, stated that the company focused on balancing inventory levels to meet demand while being conservative with cash management. This approach was part of their strategic initiatives to expand market awareness and manage financial resources effectively. Q: What are the future projections and strategic plans for Cyanotech Corp? A: Matt Custer, CEO, mentioned that the company is looking forward to the next fiscal year with a focus on managing inventory levels to meet heightened demand. They plan to continue expanding market awareness and retail channel expansion, building on the strategic initiatives implemented this year. Q: Were there any questions from analysts or investors during the call? A: Matt Custer, CEO, noted that there were no questions received during the earnings call. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
Yahoo
19-06-2025
- Business
- Yahoo
Oscar Health (NYSE:OSCR) Q1 2025 Revenue Surges 42% to US$3,046 Million
Oscar Health recently announced a significant 45% price increase over the last quarter, attributed largely to robust Q1 2025 earnings. The company reported a 42% year-over-year revenue growth to USD 3,046 million, alongside a net income increase to USD 275 million. Basic earnings per share rose to USD 1.10, from USD 0.77, signaling strong performance. This growth contrasted with the broader market, which remained flat recently but showed a 9.9% annual increase. Upcoming events, like the scheduled Annual General Meeting, along with positive financial results, likely reinforced investor confidence amidst an environment of projected annual earnings growth. We've identified 2 possible red flags with Oscar Health and understanding the impact should be part of your investment process. These 17 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch. The recent announcement from Oscar Health, demonstrating a significant 45% increase in share price due to robust Q1 2025 earnings, suggests a positive market perception of the company's current and future financial performance. This optimism aligns with the company's reported 42% year-over-year revenue growth and net income increase to US$275 million, underpinned by an earnings per share rise to US$1.10. The company's enhanced performance and strategic initiatives in AI integration and ICHRA enrollment are poised to elevate efficiency, potentially driving further revenue and earnings growth. Looking at the longer-term context, Oscar Health's total shareholder return over a three-year period, including share price and dividends, reached 330.50%, reflecting substantial appreciation. However, over the past year, Oscar Health underperformed the US Insurance industry, which returned 14%. This performance contrast highlights potential volatility and investor sentiments influenced by broader industry trends. Oscar Health's share price increase aligns closely with its fair value consensus analyst price target of US$19.36, which is 32.5% higher than the current share price of US$13.07. This target suggests potential upside, though analysts exhibit varying expectations, with the most bullish suggesting a price target of US$28.0. The positive sentiment bolstered by recent earnings reports may continue to impact future revenue and earnings forecasts, with expectations of US$13.5 billion in revenue and US$564.5 million in earnings by 2028. As Oscar Health navigates potential risks related to regulatory changes and market conditions, investors should weigh these against the optimistic forecasts. Understand Oscar Health's earnings outlook by examining our growth report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:OSCR. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19-06-2025
- Business
- Yahoo
Korn Ferry (KFY) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Economic Challenges
Fee Revenue: $712 million, up 4% year-over-year at constant currency. Adjusted EBITDA: $121 million, an increase of 8% year-over-year. Adjusted EBITDA Margin: Grew 70 basis points to 17%. Adjusted Diluted Earnings Per Share: Increased 5% to $1.32. New Business Growth: 3% year-over-year at constant currency, 5% excluding RPO. Estimated Remaining Fees Under Existing Contracts: Approximately $1.7 billion, up 12% year-over-year. Capital Return to Shareholders: $173 million through share repurchases and dividends in fiscal '25. Investment in M&A: $44 million. Capital Expenditures: $62 million focused on talent suite and technology platforms. First Quarter Fiscal '26 Outlook: Fee revenue expected to range from $675 million to $695 million; adjusted EBITDA margin between 16.8% and 17.2%; adjusted diluted EPS between $1.18 and $1.26. Warning! GuruFocus has detected 2 Warning Sign with KFY. Release Date: June 18, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Korn Ferry (NYSE:KFY) reported a 4% increase in fee revenue and a 3% rise in new business, both in constant currency, demonstrating strong financial performance. The company has achieved a 10% to 11% CAGR over the past 10 to 20 years, indicating consistent long-term growth. Korn Ferry (NYSE:KFY) has successfully diversified its revenue streams, with 77% of clients purchasing two or more solutions and over half buying three or more. The company has raised its dividend six times in the past five years, reflecting a strong commitment to returning value to shareholders. Korn Ferry (NYSE:KFY) continues to innovate with a focus on technology and AI, enhancing its offerings to drive organizational performance for clients. The economic environment remains challenging, with Korn Ferry (NYSE:KFY) describing it as a recessionary period for the past seven quarters. There is a cost of living crisis impacting consumer behavior, which could affect client spending and demand for services. The company faces uncertainty due to geopolitical tensions and macroeconomic factors, which could impact business confidence and client spending. Korn Ferry (NYSE:KFY) acknowledges that growth is elusive, and companies are slashing costs, which may impact demand for certain solutions. The monetization of Korn Ferry's intellectual property remains a significant wildcard, with potential for scalability but also uncertainty in execution. Q: Can you provide insights on new business trends and revenue trends by month, especially considering recent tariff announcements and business confidence levels? A: Gary Burnison, CEO: There's always uncertainty, and conversations ebb and flow with global events. Despite this, May was stronger than April, and April was similar to March. Overall, the firm has performed impressively in what I consider a recessionary environment for the last seven quarters. Q: What drove the 15% growth in executive search this quarter, and what are your expectations for the coming quarters? A: Gary Burnison, CEO: Growth in executive search shouldn't be viewed quarter-to-quarter due to natural fluctuations. Over the long term, Korn Ferry has consistently delivered 10-11% growth annually. Current demographic factors and demand for different leadership types are influencing this growth. Q: How are sales cycles and client spending behaviors changing across segments? A: Gary Burnison, CEO: There's a cost of living crisis impacting companies' ability to raise prices, leading to cost-cutting measures. Leadership teams are also evolving due to the need for different skills in a rapidly changing environment. Q: Can you elaborate on the impact of the fourth release of the talent suite and its expected market impact? A: Gary Burnison, CEO: The new release aims to provide seamless user experiences across hiring, development, and reward processes. The integration of our vast data sets will offer unique market advantages, and I am confident in its potential impact. Q: How is Korn Ferry managing headcount productivity and what are the future expectations? A: Gary Burnison, CEO: The monetization of our intellectual property (IP) is a significant opportunity for scalability. We are focusing on longer, transformative engagements in consulting, which may impact short-term revenue but offer long-term growth potential. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Wall Street Journal
19-06-2025
- Business
- Wall Street Journal
Standard Bank Confirms Guidance After Strong Start to Year
Standard Bank SBK -0.04%decrease; red down pointing triangle Group stuck to its annual guidance after reporting a strong performance for the first five months of the year. The South African bank on Thursday reiterated that it expects banking revenue growth in the mid-to-high single digits for 2025 with the banking-cost-to-income ratio flat to down on-year. Group return on equity should be anchored in the 17% to 20% targeted range, it said.
